Reaven [1] related MetS to the presence of resistance to insulin-mediated glucose disposal, glucose intolerance, hyperinsulinemia, increased triglycerides, decreased high-density lipoprotein cholesterol, and hypertension. This evidence concerns the gene INS and metabolic syndrome.